Suppr超能文献

普瑞巴林与右美托咪定联合用于脊髓麻醉下全膝关节置换术或全髋关节置换术后疼痛

Pregabalin and Dexmedetomidine Combined for Pain After Total Knee Arthroplasty or Total Hip Arthroplasty Performed Under Spinal Anesthesia.

作者信息

Lee Cheol, Lee Juhwan, Lee Gilho, Lee Hayeong, Koh Eunnim, Hwang Jihyo

出版信息

Orthopedics. 2018 Nov 1;41(6):365-370. doi: 10.3928/01477447-20181023-04. Epub 2018 Oct 29.

Abstract

Pregabalin and dexmedetomidine have been introduced to manage postoperative pain. This study evaluated the effect of the 2 drugs combined on pain in patients undergoing total knee or hip arthroplasty. A total of 124 patients undergoing total knee or hip arthroplasty under spinal anesthesia were randomly assigned to either group C (n=31, placebo), group P (n=33, pregabalin), group PD (n=29, pregabalin and dexmedetomidine), or group D (n=31, dexmedetomidine). One hour before spinal anesthesia, patients received 150 mg of pregabalin or placebo orally, and a bolus dose of 0.5 µg/ kg of intravenous dexmedetomidine was given over 10 minutes before induction of spinal anesthesia. This was followed by a continuous infusion of 0.5 µg/kg/h or the same calculated volume of normal saline until completion of the surgery. Clinically relevant pain for 24 hours postoperatively, including time to first analgesic request, visual analog scale score, ketorolac dose, and volume of patient-controlled analgesia consumed, was recorded. Group C had significantly longer time to first analgesic request, higher visual analog scale scores at rest and on movement, higher ketorolac dose, and higher volume of patient-controlled analgesia for the first 24 hours postoperatively compared with the other groups. Although group PD and group D had less clinically relevant pain than group P, group PD and group D were not significantly different. Dexmedetomidine was more effective than pregabalin for clinically relevant pain. Pregabalin and dexmedetomidine combined had no synergic effect compared with dexmedetomidine alone. [Orthopedics. 2018; 41(6):365-370.].

摘要

普瑞巴林和右美托咪定已被用于管理术后疼痛。本研究评估了这两种药物联合使用对接受全膝关节或髋关节置换术患者疼痛的影响。总共124例在脊髓麻醉下接受全膝关节或髋关节置换术的患者被随机分配至C组(n = 31,安慰剂)、P组(n = 33,普瑞巴林)、PD组(n = 29,普瑞巴林和右美托咪定)或D组(n = 31,右美托咪定)。在脊髓麻醉前1小时,患者口服150 mg普瑞巴林或安慰剂,在诱导脊髓麻醉前10分钟静脉注射0.5 μg/kg的右美托咪定推注剂量。随后持续输注0.5 μg/kg/h或相同计算体积的生理盐水直至手术结束。记录术后24小时的临床相关疼痛情况,包括首次镇痛需求时间、视觉模拟评分、酮咯酸剂量以及患者自控镇痛的消耗量。与其他组相比,C组术后首次镇痛需求时间显著更长,静息和活动时的视觉模拟评分更高,酮咯酸剂量更高,且术后头24小时患者自控镇痛的消耗量更高。尽管PD组和D组的临床相关疼痛比P组少,但PD组和D组之间无显著差异。右美托咪定在临床相关疼痛方面比普瑞巴林更有效。与单独使用右美托咪定相比,普瑞巴林和右美托咪定联合使用没有协同作用。[《骨科》。2018年;41(6):365 - 370。]

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验